The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid a sustained surge in technology spending, Intel reported a 25% revenue increase driven by demand for Xeon server CPUs and AI-powered PCs. Edwards Lifesciences also topped Q2 earnings and revenue estimates while raising its full-year guidance, and WEX surpassed consensus expectations fueled by higher fuel prices and broad-based segment growth. These results highlight resilience across the tech, healthcare, and financial services sectors despite broader macroeconomic shifts.
Per market data, Intel (INTC) closed at $102.62 on July 22, 2026, after reaching a session high of $106.85. In the healthcare sector, Edwards Lifesciences (EW) ended the same trading day at $84.37, moving within a range of $84.02 to $85.53. These price actions coincide with recent economic data showing Canada's annual inflation rate cooling to 2.8% and a significant jump in German Economic Sentiment to 26.3 points, according to authoritative database records.
Traders should watch for support levels at $101.48 for INTC and $84.02 for EW, based on the daily lows recorded as of the July 22, 2026 close. As the immediate impact of these earnings surprises settles, market attention will likely shift toward broader sector trends, as the upcoming economic calendar does not list specific corporate catalysts for these instruments within the next seven days.